202 related articles for article (PubMed ID: 10588458)
1. Hemostatic markers in ischemic stroke of undetermined etiology.
Ince B; Bayram C; Harmanci H; Ulutin T
Thromb Res; 1999 Nov; 96(3):169-74. PubMed ID: 10588458
[TBL] [Abstract][Full Text] [Related]
2. Looking for Our Ten Years Results for Coronary Heart Disease and Ischemic Stroke Group for the Standpoint of Haemostasis.
Ulutin T; Sönmez H; Domaniç N; İnce B; Bayram Gürel Ç; Ural D; Vural VA; Harmancı H; Özaydın A; İnce E; Buyru Sayhan N; Yılmaz Ş; Kanıgür G; Kökoğlu E
Turk J Haematol; 2002 Jun; 19(2):255-63. PubMed ID: 27264767
[TBL] [Abstract][Full Text] [Related]
3. Hemostatic markers in acute transient ischemic attacks.
Fon EA; Mackey A; Côté R; Wolfson C; McIlraith DM; Leclerc J; Bourque F
Stroke; 1994 Feb; 25(2):282-6. PubMed ID: 8303732
[TBL] [Abstract][Full Text] [Related]
4. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients.
Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
Stroke; 1991 Nov; 22(11):1369-73. PubMed ID: 1836283
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation as an acute effect of cigarette smoking.
Kimura S; Nishinaga M; Ozawa T; Shimada K
Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
[TBL] [Abstract][Full Text] [Related]
7. The molecular markers of hemostatic activation on coronary artery disease.
Ulutin T; Sönmez H; Uçişik N; Süer S; Bayram C; Kökoglu E; Sultuybek G
Thromb Res; 1997 Nov; 88(3):329-32. PubMed ID: 9526953
[TBL] [Abstract][Full Text] [Related]
8. Hemostasis activation markers in acute renal failure.
Stefanidis I; Frank D; Maurin N
Ren Fail; 1998 Jan; 20(1):147-55. PubMed ID: 9509568
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
Scharfstein JS; Abendschein DR; Eisenberg PR; George D; Cannon CP; Becker RC; Sobel B; Cupples LA; Braunwald E; Loscalzo J
Am J Cardiol; 1996 Sep; 78(5):503-10. PubMed ID: 8806332
[TBL] [Abstract][Full Text] [Related]
10. Activation of coagulation and fibrinolysis during surgery, analyzed by molecular markers.
Kambayashi J; Sakon M; Yokota M; Shiba E; Kawasaki T; Mori T
Thromb Res; 1990 Oct; 60(2):157-67. PubMed ID: 2149215
[TBL] [Abstract][Full Text] [Related]
11. [Molecular marker for hemostasis and thrombosis].
Fukutake K; Fujimaki M
Nihon Rinsho; 1989 Apr; 47(4):883-90. PubMed ID: 2664266
[No Abstract] [Full Text] [Related]
12. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC].
Koyama T; Aoki N
Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527
[TBL] [Abstract][Full Text] [Related]
13. Significance of hemostatic molecular markers during disseminated intravascular coagulation in patients with liver cirrhosis treated by endoscopic embolization for esophageal varices.
Koyama T; Kakishita E; Nakai Y; Okamoto E
Am J Hematol; 1991 Oct; 38(2):90-4. PubMed ID: 1719808
[TBL] [Abstract][Full Text] [Related]
14. The coagulation system is activated in idiopathic cardiomyopathy.
Yamamoto K; Ikeda U; Furuhashi K; Irokawa M; Nakayama T; Shimada K
J Am Coll Cardiol; 1995 Jun; 25(7):1634-40. PubMed ID: 7539015
[TBL] [Abstract][Full Text] [Related]
15. Hemostatic markers in acute stroke.
Feinberg WM; Bruck DC; Ring ME; Corrigan JJ
Stroke; 1989 May; 20(5):592-7. PubMed ID: 2718198
[TBL] [Abstract][Full Text] [Related]
16. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic molecular markers in nephrotic syndrome.
Chen TY; Huang CC; Tsao CJ
Am J Hematol; 1993 Dec; 44(4):276-9. PubMed ID: 8238000
[TBL] [Abstract][Full Text] [Related]
18. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
19. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
20. Fibrinopeptide A, prothrombin fragment 1 + 2, thrombin-antithrombin complex and D dimer before and after injection of a nonionic contrast medium (iohexol).
Sorano GG; Paoletti P; Casciu G; Mameli G; Marongiu F
Haemostasis; 1997; 27(3):125-30. PubMed ID: 9306129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
